Do not call it closed until the register and regulatory clearances that your SPA requires actually land.
China deal closings often combine payment mechanics with company-register updates, chop handovers, amalgamation or equity filings, and any SAMR merger or NSR clearances conditioned in the SPA. Sector licence amendments can lag. This wiki is the closing-filings orientation. Equity transfer explains the register piece. Merger and NSR pages are regulatory related pages. Asset deals swap in assignment filings instead.
4 questions before you choose the route.
This page identifies the right question and evidence. It does not determine the legal outcome on a reader’s facts.
SPA conditions precedent list?
CP map.
CPsRegister/AMR filing packed?
Equity related pages.
RegisterMerger/NSR clearance in hand?
Regs.
RegsChops/books handover protocol?
Control.
ChopsWorking rule: Map the regulated role before marketing or launch in China.
The signal ledger.
These facts move the question beyond a label and into a product, money-flow and control analysis.
Bring a compact evidence docket—not a pitch deck.
Give a compliance team or counsel the operating facts that reveal the perimeter.
Questions people ask before they build.
Short answers for orientation. The right result can change with the service model and current rules.
Is funds flow the same as closing?
Payment is one stream; legal control transfer is another. Align them.
Where is equity filing detail?
Open /equity-transfer-in-a-chinese-company.
Primary authorities
Reviewed sources support orientation, not a fact-specific assessment.